Hydromorphone hydrochloride
Hydromorphone Hydrochloride is a generic prescription opioid medication used to manage severe pain. It comes as oral tablets in strengths of 2 mg, 4 mg, and 8 mg, manufactured by Aurolife Pharma, LLC. As a Schedule II controlled substance, it has a high potential for abuse and addiction. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Hydromorphone Hydrochloride is a generic prescription opioid medication used to manage severe pain. It comes as oral tablets in strengths of 2 mg, 4 mg, and 8 mg, manufactured by Aurolife Pharma, LLC. As a Schedule II controlled substance, it has a high potential for abuse and addiction. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Hydromorphone hydrochloride",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Hydromorphone hydrochloride — ANDA 202159 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202159"
}
]
|
| identifier | ANDA202159 |
| issued | 2016-09-16 |
| keyword |
[
"drug-manufacturers",
"fda",
"health-care",
"prescription-drugs",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Hydromorphone hydrochloride |
